Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

NCT06124495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Bioequivalence
Diabetes Mellitus, Type 2

Interventions

DRUG: Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet

Sponsor

Galenicum Health